Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575

Atopic Dermatitis

COMPLETED PHASE2

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359

Dermatitis Atopic

ACTIVE_NOT_RECRUITING

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

NCT00480896

Dermatitis, Atopic

COMPLETED PHASE3

Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy

NCT00871208

Atopic Dermatitis

WITHDRAWN PHASE4

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618

Atopic Dermatitis

RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatitis, Atopic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

Locobase® REPAIR

Intervention Type DRUG

emollient

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Locobase® REPAIR

emollient

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has given written informed consent (parents or guardian, child if applicable)
* Moderate to severe AD
* Continuous use of topical corticosteroid or topical calcineurin inhibitor (TCI) as active treatment of AD for more than 4 weeks prior to screening (no change in topical corticosteroid or TCI is allowed between screening and day 1)
* In the opinion of the investigator, subject is unlikely to require a significant change to his/her current treatment regimen during the study period

Exclusion Criteria

* Has infected lesions
* The last assessment of any clinical study within 3 months prior to the expected date of entering into the study
* Current use of Locobase® REPAIR
* Known allergy to Locobase® REPAIR or any of its components
* Any clinical condition which, in the opinion of the investigator, would not allow safe completion of the study

Minimum Eligible Age

18 Months

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No